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ABSTRACT Laser capture microdissection (LCM) allows microscopic procurement of specific
cell types from tissue sections that can then be used for gene expression analysis. In conventional
LCM, frozen tissues stained with hematoxylin are normally used to the molecular analysis. Recent
studies suggested that it is possible to carry out gene expression analysis of formaldehyde-fixated
paraffin embedded (FFPE) tissues that were stained with hematoxylin. However, it is still unclear
if quantitative gene expression analyses can be performed from LCM cells from FFPE tissues that
were subjected to immunostaining to enhance identification of target cells. In this proof-of-princi-
ple study, we analyzed by reverse transcription-PCR (RT-PCR) and real time PCR the expression of
genes in factor VIII immunostained human endothelial cells that were dissected from FFPE tissues
by LCM. We observed that immunostaining should be performed at 48C to preserve the mRNA
from the cells. The expression of Bcl-2 in the endothelial cells was evaluated by RT-PCR and by
real time PCR. Glyceraldehyde-3-phosphate dehydrogenase and 18S were used as house keeping
genes for RT-PCR and real time PCR, respectively. This report unveils a method for quantitative
gene expression analysis in cells that were identified by immunostaining and retrieved by LCM
from FFPE tissues. This method is ideally suited for the analysis of relatively rare cell types within
a tissue, and should improve on our ability to perform differential diagnosis of pathologies as
compared to conventional LCM. Microsc. Res. Tech. 72:908–912, 2009. VC 2009 Wiley-Liss, Inc.
INTRODUCTION
A method based on laser capture microdissection
(LCM) that would allow for quantitative gene expres-
sion analyses of specific target cells in tissue sections
could be very useful to several experimental and
clinical fields. To date, formaldehyde as a 10% neutral
buffered formalin is the most widely used as a fixative
for various human tissues. As with DNA, formaldehyde
reacts with RNA forming an N-methylol (N-CH2OH)
followed by an electrophilic attack to form a methylene
bridge between amino groups. Adenine is the most
susceptible nucleotide to electrophilic attack and it is
likely that the adenines within the mRNA sequence
and the poly(A) tail of mRNA will be modified in the
formaldehyde-fixated paraffin embedded (FFPE) sec-
tions to varying degrees. Thus, it is normally consid-
ered that RNA isolated from FFPE sections are less
suitable for reverse transcription (cDNA synthesis), as
compared to RNA-isolated frozen tissue sections
(Srinivasan et al., 2002). However, a recent report has
suggested that it is possible to perform gene expression
analysis from FFPE tissues (Pagedar et al., 2006).
The tumor microenvironment is composed of several
cell types, of which the endothelial cells constitute a
small fraction of the overall cell number. Therefore, if
one needs to quantitatively analyze gene expression
specifically in endothelial cells, they have to be
somewhat selectively removed from the tissue, without
contamination of other cell types. To overcome this
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technical problem, we developed a novel strategy of
immuno-LCM in FFPE tissues, which may greatly
facilitate the identification of the target cells (i.e.,
tumor-associated endothelial cells). Using such
strategy, we have recently reported, using a severe
combined immunodeficient (SCID) mouse model of
human tumor angiogenesis, that Bcl-2 orchestrates a
tumor-endothelial cell crosstalk that promotes tumor
growth (Kaneko et al., 2007). In the analysis, we used
the SCID mouse model of human tumor angiogenesis.
It allows for the study of human tumors in murine
hosts by implanting defined endothelial and tumor cell
populations in biodegradable scaffolds (Nör et al.,
1999, 2001a). We have demonstrated that this method
allows for the development of functional human blood
vessels that anastomize with the mouse vasculature
(Nör et al., 2001a). Notably, it is suitable for studying
both physiologic (when only human endothelial cells
are implanted), or pathologic angiogenic processes
(when both tumor cells and endothelial cells are coim-
planted). Here, we used the SCID mouse model of
human tumor angiogenesis as a platform to character-
ize in detail the method developed for quantitative
gene expression analysis in LCM-retrieved endothelial
cells after immunostaining from FFPE-engineered
tumor tissues (Kaneko et al., 2007).
MATERIALS AND METHODS
Cells
Human dermal microvascular endothelial cells
(HDMEC; Cambrex, Walkersville, MD) stably trans-
duced with Bcl-2 (HDMEC-Bcl-2) and empty vector
controls HDMEC-LXSN were cultured in EGM2-MV
(Cambrex), as described previously (Kaneko et al.,
2007; Karl et al., 2005; Nör et al., 1999, 2001a,b). Oral
squamous cell carcinoma cells (OSCC3; gift of M.
Lingen, University of Chicago) were cultured in
DMEM supplemented with 10% fetal bovine serum.
Severe Combined Immunodeficient (SCID)
Mouse Model of Human Angiogenesis
The care and treatment of experimental animals
were in accordance with University of Michigan insti-
tutional guidelines. Porous poly-L-lactic acid (PLLA;
Boehringer Ingelheim, Germany) scaffolds (6 mm 3
6 mm 3 1 mm biodegradable) with an average pore
diameter of 180 lm were fabricated, as previously
described (Nör J.E., 2001). Just before implantation,
scaffolds were seeded with 0.9 3 106 HDMEC and 0.1
3 106 tumor cells (OSCC3) in a 1:1 Matrigel/EGM2-
MV mix. Five- to nine-week-old male SCID mice (n 5
5) (CB-17, Chales River Laboratories, Wilmington,
MA) were anesthetized with ketamine and xylazine,
and two scaffolds were implanted subcutaneously in
the dorsal region of each mouse. Twenty-eight days
after transplantation, mice were euthanized, and the
scaffolds were retrieved, fixed for 10 h in 10% buffered
formaldehyde at 48C. Then, the samples were cut in
two pieces, one for paraffin blocks, and the other for
frozen blocks. Eight micrometer serial sections from
each piece were cut, and mounted on PEN foil slides
(Leica Microsystems, Bannock Burn, IL) for LCM.
Immunostaining for Paraffin Sections
To stain the microvascular networks formed by the
implanted human endothelial cells, immunoperoxidase
staining was conducted using a mouse antihuman Fac-
tor VIII monoclonal antibody (1:100 dilution; Lab
Vision, Fremont, CA). Slide-mounted tissue sections
were deparaffinized twice with 3 min xylene washes at
room temperature, and rehydrated through a series of
graded ethanol at 48C. A working dilution of 0.125%
trypsin was used to pretreat these sections for 30 min
at room temperature. Endogenous peroxidase activity
was blocked by incubation with 3% hydrogen peroxide
with methanol for 3 min at 48C. Immunostaining was
performed as described earlier (Kaneko et al., 2007,
2001a,b). A first incubation was made with mouse anti-
Factor VIII (diluted 1:100) for 16 h at 48C. Sections
were then incubated with biotinylated antimouse IgG
(Vector Laboratories, Burlingame, CA; diluted 1:500)
for 1 h at 48C and incubated with avidin-biotin-peroxi-
dase complex (Elite ABC kit; Vector) at 48C. Peroxidase
activity was developed in diaminobenzidine-H2O2 solu-
tion (DAB substrate kit; Vector) for 3 min at room tem-
perature. Sections were then air-dried at 48C. Negative
control staining was always conducted in parallel by
the omission of the primary antibody, antimouse IgG,
or avidin-biotin-peroxidase complex.
Immunostaining for Frozen Sections
Frozen sections were cut in a cryostat (Leica,
Germany), and were incubated with anti-Factor VIII
antibody (1:500 dilution). This was followed by the
same steps of immunostaining for paraffin sections.
LCM
After immunostaining, a three-step dissection strat-
egy was performed using a LCM microscope (Leica AS
LMD; Leica Microsystems) with a pulsed 337 nm UV
laser (Leica Microsystems). Blood cells in Factor VIII-
positive capillaries were excluded first. Then Factor
VIII-positive endothelial cells (1,500) were dissected
and collected into individual tubes filled with RNA-
later1 (Ambion, Austin, TX) and immediately placed
on ice. Cells without a nucleus were excluded from the
cell count. Then, tumor cells surrounding the blood
vessels were collected similarly. Experiments were
always carried out in duplicate. The FFPE blocks used
in this study were 1-year-old.
RT-PCR
Total RNA from paraffin-embedded tissue sections
was extracted using TRIzol reagent (Invitrogen), and
purified with RNeasy Mini kits (Qiagen), as we
described (Kaneko et al., 2007, 2008). Its purity (Mo,
SGman: OD260/280 5 1.9–2.1) was determined photomet-
rically (Ultrospec 2000, Pharmacia Biotech, Germany).
cDNA synthesis and PCR amplification were done in
single tubes with SuperScript one-step reverse tran-
scription-PCR (RT-PCR) and Platinum Taq kit (Invi-
trogen) using simultaneously a human Bcl-2 primer
set and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) primer set. The sequence of the primers used
here were as follows: Bcl-2, sense, CTGCGAA
GAACCTTGTGTGA and antisense TGTCCCTAC
CAACCAGAAGG; and GAPDH, sense, CATGGCCTC
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CAAGGAGTAAG and antisense, AGGGGTCTACAGG
CAACTG. Negative control reaction was always con-
ducted in parallel by using water instead of RNA. The
PCR products were detected by standard agarose gel
with 1.5% ethidium bromide.
Real-Time PCR
Total RNA was extracted and purified from LCM-
retrieved samples, as described above. First-strand
complementary DNA (cDNA) synthesis was performed
with TaqMan1 reverse transcription reagents (Applied
Biosystems). Probe and primer sets of TaqMan Gene
Expression Assays (Hs00608023_m1; Bcl-2,
Hs00174103_m1; and Hs99999901_s1; 18S) were
obtained from Applied Biosystems. Total RNA at 0.02
lg per 30 lL of reaction mixture was prepared by Taq-
Man Universal PCR Master Mix (Applied Biosystems).
For standard RNA, we used TaqMan One-step RT-PCR
Master Mix Reagents (Applied Biosystems). The reac-
Fig. 1. The overall strategy used here for quantitative gene expression analysis of immunostained
FFPE tissue sections. [Color figure can be viewed in the online issue which is available at www.
interscience.wiley.com.]
Fig. 2. Step-by-step characterization of the technique based on
LCM used for retrieval of either endothelial cells or tumor cells from
FFPE tissue sections. (a) H&E staining of this engineered tumor
tissue that was coimplanted with OSCC3 (oral squamous cell carci-
noma cells) and HDMEC-Bcl-2 (endothelial cells stably transduced
with Bcl-2). (b) Factor VIII1 endothelial cells (arrows). There are
both well-vascularized and unclearly vascularized endothelial cells.
BV: blood vessel. (c) Removal of blood cells. (d) Retrieval of factor
VIII1 endothelial cells. (e) Retrieval of tumor cells adjacent to blood
vessels. Bar 5 500 lm. [Color figure can be viewed in the online issue
which is available at www.interscience.wiley.com.]
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tions were performed in 96-well clear optical reaction
plate using ABI7700 Sequence Detection System
(Applied Biosystems), and the data were normalized by
the data of 18S controls. All reactions were performed
in triplicate, each run contained at least one negative
and one positive controls, and three independent
experiments were performed to confirm reproducibility
of results.
The overall strategy used here for quantitative gene
expression analysis of immunostained FFPE tissue sec-
tions is summarized in Figure 1. After tumor retrieval,
samples were processed for FFPE, sectioned, mounted
on LCM slides, and immunostained using the avidin-
biotin-peroxidase method. Following the LCM, RNA
extraction and PCR analysis were performed.
Statistical Analysis
For statistical comparison of two experimental
groups, we used Student’s t-tests using Prism 5.0
(Graphpad, San Diego, CA).
RESULTS
The step-by-step LCM procedure is shown in Figure
2. We first retrieved blood cells, and then Factor
VIII-immunostained endothelial cells, and lastly the
surrounding tumor cells. Notably, Factor VIII immuno-
staining allowed for clear identification of the endothe-
lial cells.
To confirm if the tissues dissected by LCM were with-
out contamination, we performed RT-PCR analysis for
vascular endothelial cell growth factor receptor 2
(VEGFR2: a specific marker for endothelial cells) and
E-cadherin (a specific marker for cells of ectodermal
origin). RT-PCR analysis showed that mRNA from dis-
sected tissues was adequate for PCR analysis for target
genes. Furthermore, dissected endothelial cells did not
express E-cadherin, and tumor cells did not express
VEGFR2, confirming the quality and origin of the RNA
(Fig. 3). As shown in Figure 4a, Bcl-2 and GAPDH
gene expression in both FFPE and frozen tissues was
detected by RT-PCR. Notably, we were able to compare
the expression levels between tumor cells and endothe-
lial cells in paraffin samples by real time PCR (Fig. 4b).
DISCUSSION
LCM is normally used to demonstrate the presence
of specific gene transcripts in cryosectioned tissues
(Cristobal et al., 2004, 2005). LCM of immunostained
frozen tissue sections has been used successfully for
gene expression analysis (Fend et al., 1999; Stoebner
et al., 2008). We have also reported that gene expres-
sion of some antigen presenting cell-related molecules,
such as HLA-DR a-chain, CD83, and CD86, can be ana-
lyzed in LCM-retrieved HLA-DR-expressing cells from
immunostained frozen tissue sections (Kaneko et al.,
2008). RNA recovery from several kinds of FFPE tis-
sues is now possible (Su et al., 2004), although frozen
tissue sections may allow us to retrieve better quality
and more amount of mRNA, as compared to mRNA
from the FFPE tissues. However, no technical reports
have described quantitative gene expression analysis
after LCM of immunostained FFPE tissues. In this
report, we describe a method for gene expression anal-
Fig. 3. Quality control check of RNA from endothelial cells or
tumor cells from FFPE tissues using VEGFR2 (a specific marker for
endothelial cells) and E-cadherin (a specific marker for cells of ecto-
dermal origin).
Fig. 4. PCR analysis for LCM samples. (a) Reverse transcription/
polymerase chain reaction (RT-PCR) to evaluate levels of Bcl-2 and
GAPDH mRNA expression in endothelial cells in FFPE or frozen tis-
sue sections that were engineered in SCID mice. (b) Real-time PCR
used to quantify Bcl-2 expression in endothelial cells and tumor cells
retrieved from FFPE tissue sections. Specimens were obtained from
engineered tumor tissues. Data presented from real-time PCR experi-
ments reflect the expression level of Bcl-2 normalized by 18S. *, P <
0.001 (t-test).
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ysis of Factor VIII-expressing endothelial cells micro-
dissected from FFPE tissues. This method allowed us
to retrieve mRNA from a predetermined cell type in
histologically defined areas of routinely prepared
FFPE tissues. We have also reported that this method
can be used in FFPE human surgical materials such as
those from head and neck carcinomas (Kaneko et al.,
2007).
We here demonstrated that formaldehyde, a cross-
linking fixative, do not prevent us from extracting
enough RNA for RT-PCR or real time PCR, at least for
Bcl-2 and house keeping gene amplification. These
results are in agreement with previous reports assess-
ing PCR amplication of RNA in tissues recovered from
paraffin blocks by other methods (Ben-Ezra et al.,
1991; Koopmans et al., 1993).
The present method of selective LCM-retrieval may
be useful to compare gene expression patterns in tumor
cells versus endothelial cells during tumor progression
or tumor angiogenesis. This method could also be use-
ful for quantitative gene expression analysis in blood
vessels from tumors of patients that have been treated
with antiangiogenic drugs, allowing for validation of
the effect of drug on the expected targets. Such capabil-
ity might be exceedingly useful for the evaluation of
the bioactivity of new drugs.
In conclusion, we demonstrated that immunostain-
ing-based LCM method presented here allowed us to
quantify Bcl-2 and housekeeping gene mRNAs from en-
dothelial cells in FFPE tissue sections. This method
may be suited for the analysis of relatively rare cell
types within a tissue, and should improve on our abil-
ity to perform differential diagnosis of pathologies as
compared to conventional LCM.
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